Cervical Cancer: A Major Public Health Challenge in India
Cervical cancer remains one of the most significant health threats to women in India. Every year, more than one lakh women are diagnosed with the disease, and tens of thousands lose their lives to it. Despite being largely preventable through vaccination, screening, and early treatment, cervical cancer continues to affect women across the country. Recognizing this burden, India has taken a major step toward prevention by launching the world’s largest free HPV vaccination campaign.
The Launch of a Historic Vaccination Programme
On February 28, 2026, Prime Minister Narendra Modi inaugurated the nationwide HPV vaccination programme from Ajmer, Rajasthan. The initiative aims to vaccinate around 11.5 to 12 million girls aged 14 every year. This age group has been chosen because vaccination before potential exposure to the Human Papillomavirus offers the strongest protection against infection and related cancers.
Vaccine Used and Its Effectiveness
The programme uses Gardasil 4, a quadrivalent HPV vaccine that protects against four major HPV types. HPV types 16 and 18 are responsible for the majority of cervical cancer cases, while types 6 and 11 are associated with genital warts. The vaccine is administered as a single dose, which simplifies logistics and allows the programme to reach a large number of beneficiaries efficiently while maintaining high effectiveness.
Free Vaccination Through Government Health Facilities
The HPV vaccine is being provided free of cost through government healthcare facilities across the country. Vaccination sessions are taking place in Ayushman Arogya Mandirs, Primary Health Centres, Community Health Centres, district hospitals, and medical colleges. During the intensive campaign phase, many vaccination sessions are also being conducted in schools to maximize coverage among eligible girls. The vaccination programme is voluntary and requires parental consent.
Global Recognition and Support
The initiative has received strong international attention and recognition. Global health leaders have described the programme as the largest free HPV vaccination drive ever undertaken. India’s strategy focuses on prevention through vaccination, widespread screening of women, early detection of disease, and timely treatment, forming a comprehensive approach toward eliminating cervical cancer as a public health problem.
Why This Programme Matters
Cervical cancer is caused by persistent infection with high risk strains of HPV that are primarily transmitted through sexual contact. Vaccinating girls before exposure to the virus provides near complete protection against the most dangerous HPV types. By focusing on adolescent girls and adopting a simplified single dose schedule, the programme aims to significantly reduce future cervical cancer cases and deaths in India.
Moving Toward Cervical Cancer Elimination
This vaccination drive marks a major milestone in India’s public health journey. By integrating HPV vaccination into long term immunization programmes and combining it with screening and treatment initiatives, India is taking decisive steps toward eliminating cervical cancer. The success of the programme will depend on awareness, community participation, and continued collaboration between healthcare providers, schools, parents, and policymakers.
